Motion Displacement Test on show for World Glaucoma Day

Article

The Motion Displacement Test (MDT), developed by Moorfields Eye Hospital in partnership with UCL Institute of Ophthalmology and City University London will be on show during World Glaucoma Day (March 12th) to demonstrate some of the latest glaucoma diagnostic equipment.

The Motion Displacement Test (MDT), developed by Moorfields Eye Hospital in partnership with UCL Institute of Ophthalmology and City University London will be on show during World Glaucoma Day (March 12th) to demonstrate some of the latest glaucoma diagnostic equipment. The MDT tests a patient's field of vision and will run on a standard computer, which means it may offer an effective, portable detection method out in the community. The patient is asked to look at a central white spot and to click the computer mouse each time a line on the screen is seen to move. The idea was originated by Professor Fred Fitzke at the UCL Institute of Ophthalmology and has been developed into a clinical tool by research teams led by Mr Ted Garway-Heath at Moorfields and Dr David Crabb at City University London.

Dr Faisal Ahmed, glaucoma fellow of the Western Eye Hospital, told Ophthalmology Times Europe: “The main events include a screening at the UK's parliament, organized by Moorfields Eye Hospital and the RNIB, aimed at persuading the general public to get their eyes tested. Also the International Glaucoma Association is inviting people to use some of the latest technology under development for future diagnosis programmes in hospitals. This includes the Heidelberg Tomograph 3, HRT3 and the Ocular Response Analyser.”

The Glaucoma Alliance is a new organization, looking into glaucoma diagnosis and management and in the UK is playing an integral part in raising awareness on 12th March. The Alliance comprises a diverse community of health professionals including glaucoma specialists the Royal National Institute for the Blind (RNIB), The International Glaucoma Association, optometrists and pharmaceutical companies and other charities. This year it has been responsible for producing a poster and assisting in distributing information to opticians, hospitals and GP surgeries throughout the UK. In addition online information and weblinks were made with the General Optical Council and Royal College of Ophthalmologists.

Dr Ahmed said: “The Glaucoma Alliance has made great efforts to inform the general public via a ‘grass roots’ approach. The RNIB has designed and produced over 7,000 posters for distribution to the community and the IGA has provided information leaflets as well. So far we are posting posters to over 500 health care centres, over 200 places of worship and high street chemists. In addition not only have independent opticians put up posters but Specsavers and Boots are also taking part. Pfizer, Allergan and Alcon are all distributing posters to hospitals and GP surgeries.

“Charities have also become involved and The Royal Mail has put up posters for its 200,000 staff. The message is that we need to make everyone from all backgrounds have their eyes checked.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.